CARLY ROUTZAHN: Open Payments
NPI 1518303189 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 41 payments from 10 companies in 2025. Trend: 2023 $551 · 2024 $822 · 2025 $986
Food & beverage: $703Education: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $304 |
| Janssen Biotech, Inc. | 9 | $280 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $123 |
| UCB, Inc. | 5 | $94 |
| Lilly USA, LLC | 2 | $52 |
| Incyte Corporation | 2 | $37 |
| GENZYME CORPORATION | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Organon LLC | 3 | $13 |
Products named: TREMFYA, BOTOX, Bimzelx, RINVOQ, DUPIXENT, TALTZ, ILUMYA, OPZELURA.
Industry payments across CO — which companies pay providers there.
